Rough Rice (ZR julio 2025)/ ECBOT
ZR08/11/2024 0:00:00 | Diferencia -0.075 | Apertura | Máximo del día | Price Change Band | Cierre del día anterior |
---|---|---|---|---|---|
15.065USD | -0.50% | 15.065 | 15.065 | 15.065 | 15.140 |
GlobeNewswire
22/08
Telix 2024 Half-Year Results: Strong Commercial Revenue and Profit Growth to Support Strategic Prior...
GlobeNewswire
21/08
Monopar Receives Clearance to Proceed with Phase 1 Therapeutic Trial of Novel Radiopharmaceutical in...
GlobeNewswire
14/08
Monopar Announces Initial Data for First Patient Dosed in Radiopharma Phase 1 Clinical Trial of MNPR...
GlobeNewswire
09/08
Monopar Therapeutics Reports Second Quarter 2024 Financial Results and Recent Developments
Newsfile Corp
09/07
Teako Mobilizes Field Crew to Copper-Cobalt-Zinc Projects Lomunda-Venna and Tydalen Utilizing Recent...
GlobeNewswire
09/07
Monopar Announces First Patient Enrolled in First-in-Human Phase 1 Trial for Its Novel Radiopharmace...
GlobeNewswire
25/06
Monopar Announces MNPR-101-RIT Abstract Accepted as a Top-Rated Oral Presentation at EANM’24
GlobeNewswire
20/06
Nusano to Host Virtual Event “Office Hours: Radiopharmaceuticals” on June 28, 2024
GlobeNewswire
10/06
Monopar Presents Data Showcasing the Appeal of uPAR as a Radiopharma Cancer Target and of its lead C...
GlobeNewswire
05/06
TRIUMPH UNVEILS LIMITED EDITION MY25 SPEED TRIPLE 1200 RR IN COLLABORATION WITH BREITLING
GlobeNewswire
23/05
FibroGen Announces Presentation of Positive Interim Data from the Phase 1b Study of FG-3246 (FOR46) ...
GlobeNewswire
09/05
Monopar Therapeutics Reports First Quarter 2024 Financial Results and Strategic Focus on its Radioph...
GlobeNewswire
02/05
Akoya Biosciences and Shanghai KR Pharmtech Announce Chinese Regulatory Agency Premarket Approval fo...
GlobeNewswire
18/04
Monopar Announces Radiopharma Presentation Selected for Society of Nuclear Medicine and Molecular Im...
- Primera página
- Atrás
- 1
- 2
- 3
- 4
- Siguiente
- Última página